Wells Fargo’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$218K Sell
89,180
-111,096
-55% -$223K ﹤0.01% 4657
2025
Q4
$274K Buy
200,276
+55,415
+38% +$73.1K ﹤0.01% 4891
2025
Q3
$180K Buy
144,861
+17,310
+14% +$20.6K ﹤0.01% 4991
2025
Q2
$144K Buy
127,551
+20,254
+19% +$26.9K ﹤0.01% 4961
2025
Q1
$157K Buy
107,297
+2,704
+3% +$5.1K ﹤0.01% 4851
2024
Q4
$223K Buy
104,593
+23,779
+29% +$58.6K ﹤0.01% 4735
2024
Q3
$226K Buy
80,814
+12,956
+19% +$34.5K ﹤0.01% 4488
2024
Q2
$158K Buy
67,858
+12,654
+23% +$37.3K ﹤0.01% 4663
2024
Q1
$247K Buy
55,204
+1,034
+2% +$4.31K ﹤0.01% 4342
2023
Q4
$174K Sell
54,170
-114,796
-68% -$326K ﹤0.01% 4543
2023
Q3
$536K Buy
168,966
+3,189
+2% +$14K ﹤0.01% 3733
2023
Q2
$824K Buy
165,777
+33,750
+26% +$183K ﹤0.01% 3601
2023
Q1
$652K Buy
132,027
+126,707
+2,382% +$813K ﹤0.01% 3667
2022
Q4
$33.5K Sell
5,320
-1,875
-26% -$17.4K ﹤0.01% 5039
2022
Q3
$78K Buy
7,195
+202
+3% +$2.75K ﹤0.01% 4740
2022
Q2
$79K Sell
6,993
-6,221
-47% -$55.2K ﹤0.01% 4775
2022
Q1
$121K Sell
13,214
-25,677
-66% -$267K ﹤0.01% 5224
2021
Q4
$580K Buy
38,891
+18,456
+90% +$326K ﹤0.01% 4541
2021
Q3
$526K Buy
20,435
+9,645
+89% +$229K ﹤0.01% 4633
2021
Q2
$281K Buy
10,790
+5,468
+103% +$156K ﹤0.01% 4888
2021
Q1
$187K Sell
5,322
-29,659
-85% -$1M ﹤0.01% 5182
2020
Q4
$883K Buy
34,981
+5,854
+20% +$191K ﹤0.01% 4119
2020
Q3
$1.1M Buy
29,127
+8,695
+43% +$328K ﹤0.01% 3788
2020
Q2
$874K Sell
20,432
-8,265
-29% -$299K ﹤0.01% 3914
2020
Q1
$558K Sell
28,697
-1,251
-4% -$29.8K ﹤0.01% 3955
2019
Q4
$777K Buy
29,948
+2,729
+10% +$75.2K ﹤0.01% 4031
2019
Q3
$742K Buy
27,219
+2,323
+9% +$66.2K ﹤0.01% 4077
2019
Q2
$668K Sell
24,896
-14,625
-37% -$407K ﹤0.01% 4176
2019
Q1
$1.14M Buy
39,521
+4,644
+13% +$135K ﹤0.01% 3776
2018
Q4
$939K Buy
+34,877
New +$927K ﹤0.01% 3888

Other funds holding ALLO